Chủ đề

#merck

2 bài viết

#pharmaceuticals #earnings #healthcare #moderna #cancer-vaccine #biotech

Bài thuyết trình dành cho Cổ đông/Nhàanalyst của Merck & Co., Inc. (MRK) - Bản chiếu slide (NYSE:MRK) 26-10-2026

Merck & Co. has published an updated shareholder and analyst presentation detailing its strategic outlook and pharmaceutical pipeline. The report highlights core therapeutic areas, oncology developments, and commercial product performance. Investors are evaluating the updates for insights into revenue growth and pipeline progression.

3,4 N2259

Cổ phiếu·2 tuần trước

Doctors call Moderna, Merck cancer vaccine data a major advancement — despite Wall Street reaction

Moderna and Merck's melanoma vaccine data has received significant praise from medical specialists despite a muted market response. The results represent a clinically meaningful advancement for patients undergoing cancer surgery.

2,1 N10911